|
Volumn 10, Issue 12, 2008, Pages 1815-1816
|
Canary in a coal mine? Interest in bupropion SR use among smokers in the COMPASS trial
a b c a c c a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
NICOTINE DERIVATIVE;
VARENICLINE;
BEHAVIOR THERAPY;
CIGARETTE SMOKING;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG APPROVAL;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
FOOD AND DRUG ADMINISTRATION;
GOOD CLINICAL PRACTICE;
HEALTH CARE SYSTEM;
HUMAN;
INTERNET;
LETTER;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
MOTIVATION;
NICOTINE REPLACEMENT THERAPY;
PATIENT ATTITUDE;
PATIENT COUNSELING;
PATIENT EDUCATION;
PATIENT PARTICIPATION;
PATIENT REFERRAL;
PRIORITY JOURNAL;
SMOKING CESSATION;
SUSTAINED RELEASE FORMULATION;
TELEPHONE;
TOBACCO DEPENDENCE;
UNITED STATES;
BUPROPION;
COMBINED MODALITY THERAPY;
CONTROLLED CLINICAL TRIALS AS TOPIC;
DELAYED-ACTION PREPARATIONS;
DIRECTIVE COUNSELING;
HUMANS;
INTERNET;
PATIENT COMPLIANCE;
SMOKING;
SMOKING CESSATION;
TELEPHONE;
TREATMENT OUTCOME;
|
EID: 57049105643
PISSN: 14622203
EISSN: 1469994X
Source Type: Journal
DOI: 10.1080/14622200802488358 Document Type: Letter |
Times cited : (6)
|
References (7)
|